Holcakova, Jitka <br/><br/>
The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral properties.  [electronic resource] 

 -  Antiviral chemistry & chemotherapy  Jan 2010 
 - 133-42 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2040-2066 
<br/><br/><label>Standard No.: </label>10.3851/IMP1460  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--pharmacology<br/>Cyclin-Dependent Kinases--antagonists & inhibitors<br/>Humans<br/>Inhibitory Concentration 50<br/>Protein Kinase Inhibitors--pharmacology<br/>Purines--pharmacology<br/>Virus Physiological Phenomena--drug effects<br/>Virus Replication--drug effects<br/>Viruses--enzymology